USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/11820
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMării, Elena
dc.contributor.authorSamohvalov, Elena
dc.contributor.authorBenesco, Irina
dc.date.accessioned2020-09-30T11:12:07Z
dc.date.available2020-09-30T11:12:07Z
dc.date.issued2020
dc.identifier.citationMĂRII, Elena, SAMOHVALOV, Elena, BENESCO, Irina. Chronic inflammation as a new cardiovascular disease factor. In: MedEspera: the 8th Internat. Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2020, p. 214-215.en_US
dc.identifier.urihttps://medespera.asr.md/wp-content/uploads/ABSTRACT-BOOK.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/11820
dc.descriptionDepartment of Internal Medicine, Cardiology, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova, The 8th International Medical Congress for Students and Young Doctors, September 24-26, 2020en_US
dc.description.abstractIntroduction. Cardiovascular disease (CVD) is a major public health problem, in most areas of the world. While traditional risk factors for the development of CVD have been researched, the science community has recently identified chronic Inflammation as an additional risk factor. Inflammation is the result of the body's immune system activity recognizing and removing harmful stimuli to start the healing process. Chronic inflammation is referred to as a long-term disorder. Chronic inflammatory disorders include diseases such as rheumatoid arthritis (RA), systemic sclerosis (SSc), systemic lupus erythematosus (SLE), ankylosing spondylitis (AS) and psoriatic arthritis (PsA) etc., which play a crucial role in the process of atherogenesis. Aim of the study. This research was on studying cardiovascular patients, that previously have been diagnosed with a form of chronic inflammation, to show that patients with chronic inflammatory diseases are likely at high risk of developing CVD. Materials and methods. The aim of the research consisted in studying cardiovascular patients, that have been previously diagnosed with a form of chronic inflammation, to show that patients with chronic inflammatory diseases are likely to be at a high risk of developing CVD. Results. By studying the significant inflammatory indicators like C-reactive protein, fibrinogen, Cytokines interleukin, the helper T cells, LDL cholesterol, triglycerides, etc. and their effects on atherosclerosis we can underline the pathophysiology of atherogenesis. When the pro-inflammatory activity starts, it also commences the alteration of lipoprotein concentrations, oxidative stress, and macrophage accumulation, the injury of the endothelial and the activation of the immune system. All these factors and many others are increasing the risk of the atherosclerosis/arteriosclerosis and supported by the traditional factors they create the best conditions for the development of CVD. Patients with rheumatoid arthritis are in the group of an increased risk of CVD; the EULAR recommendations in 2017, updated in 2019, announced that the estimated risks are multiplied by 1.5- 2 for all patients with RA. The same data was found on systemic lupus erythematosus, in which the risks increase by 2-3 times. A similarity was suggested also on psoriatic arthritis and systemic sclerosis. Conclusions. Chronic inflammatory disorders, influenced by their pro-inflammatory effects are relevant as the new risk factors of Cardiovascular disease such as atherosclerosis, arteriosclerosis, acute coronary syndrome, etc.en_US
dc.language.isoenen_US
dc.publisherMedEsperaen_US
dc.subjectchronic inflammationen_US
dc.subjectcardiovascular diseaseen_US
dc.subjectrisk factoren_US
dc.subjectatherosclerosisen_US
dc.titleChronic inflammation as a new cardiovascular disease factoren_US
dc.typeArticleen_US
Appears in Collections:MedEspera 2020

Files in This Item:
File Description SizeFormat 
Marii_Elena.pdf445.49 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback